In the BioHarmony Drug Report Database
Candesartan cilexetil
Atacand (candesartan cilexetil) is a small molecule pharmaceutical. Candesartan cilexetil was first approved as Atacand on 1998-06-04. It is used to treat diabetic nephropathies, heart failure, hypertension, and left ventricular dysfunction in the USA. It is known to target type-1 angiotensin II receptor.
Trade Name
|
Atacand |
|---|---|
Common Name
|
candesartan cilexetil |
ChEMBL ID
|
CHEMBL1014 |
Indication
|
diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction |
Drug Class
|
Angiotensin II receptor antagonists |
Image (chem structure or protein)